US Exempts India from 100% Tariffs on Some Specialty Drugs
The US has exempted India and 19 other countries from 100% tariffs on certain patented specialty pharmaceuticals and ingredients. This exemption covers rare-disease drugs, gene and cell therapies, and infertility treatments. Indian pharma stocks like Sun Pharma and Aurobindo Pharma are in focus following this decision. Generic medicines remain excluded from Section 232 tariffs.
ET Markets·1d ago



